Prognosis of Variant Angina Manifesting as Aborted Sudden Cardiac Death
Jung-Min Ahn1, Ki Hong Lee2, Sang-Yong Yoo3
1Heart Institute, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Insights
Patients with variant angina and aborted sudden cardiac death (ASCD) face a significantly worse long-term prognosis. Early intervention with implantable cardioverter-defibrillators (ICDs) may improve outcomes in these high-risk individuals.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- The long-term prognosis for patients experiencing aborted sudden cardiac death (ASCD) alongside variant angina remains largely unknown.
- Variant angina, also known as Prinzmetal's angina, is characterized by coronary artery spasms causing chest pain.
Purpose of the Study:
- To evaluate and compare the long-term mortality rates and ventricular tachyarrhythmic events in patients with variant angina, stratified by the presence or absence of ASCD.
- To identify predictors associated with ASCD manifestation in variant angina patients.
Main Methods:
- A retrospective cohort study involving 188 patients with variant angina and ASCD and 1,844 patients with variant angina without ASCD, enrolled across 13 South Korean heart centers from March 1996 to September 2014.
- Primary endpoint was cardiac death; secondary endpoints included all-cause mortality and recurrent ventricular tachyarrhythmia. Statistical analysis involved calculating odds ratios (OR), confidence intervals (CI), and hazard ratios (HR).
Main Results:
- Predictors for ASCD included older age, hypertension, hyperlipidemia, family history of sudden cardiac death, multivessel spasm, and left anterior descending artery spasm.
- Over a median follow-up of 7.5 years, ASCD patients exhibited significantly higher cardiac death rates (24.1 vs. 2.7 per 1,000 patient-years; adjusted HR: 7.26) and all-cause mortality (27.5 vs. 9.6 per 1,000 patient-years; adjusted HR: 3.00).
- The incidence of recurrent ventricular tachyarrhythmia was 32.4 per 1,000 patient-years in ASCD patients. A non-significant trend towards lower cardiac death was observed in the 24 ASCD patients who received implantable cardioverter-defibrillators (ICDs).
Conclusions:
- Patients with variant angina presenting with ASCD have a demonstrably worse long-term prognosis compared to those without ASCD.
- The findings support the consideration of ICDs for secondary prevention in high-risk variant angina patients with ASCD, as current vasodilator therapies may be suboptimal.
Background:
The long-term prognosis of patients with variant angina presenting with aborted sudden cardiac death (ASCD) is unknown.
Objectives:
The purpose of this study was to evaluate the long-term mortality and ventricular tachyarrhythmic events of variant angina with and without ASCD.
Methods:
Between March 1996 and September 2014, 188 patients with variant angina with ASCD and 1,844 patients with variant angina without ASCD were retrospectively enrolled from 13 heart centers in South Korea. The primary endpoint was cardiac death.
Results:
Predictors of ASCD manifestation included age (odd ratio [OR]: 0.980 by 1 year increase; 95% confidence interval [CI]: 0.96 to 1.00; p = 0.013), hypertension (OR: 0.51; 95% CI: 0.37 to 0.70; p < 0.001), hyperlipidemia (OR: 0.38; 95% CI: 0.25 to 0.58; p < 0.001), family history of sudden cardiac death (OR: 3.67; 95% CI: 1.27 to 10.6; p = 0.016), multivessel spasm (OR: 2.06; 95% CI: 1.33 to 3.19; p = 0.001), and left anterior descending artery spasm (OR: 1.40; 95% CI: 1.02 to 1.92; p = 0.04). Over a median follow-up of 7.5 years, the incidence of cardiac death was significantly higher in ASCD patients (24.1 per 1,000 patient-years vs. 2.7 per 1,000 patient-years; adjusted hazard ratio [HR]: 7.26; 95% CI: 4.21 to 12.5; p < 0.001). Death from any cause also occurred more frequently in ASCD patients (27.5 per 1,000 patient-years vs. 9.6 per 1,000 patient-years; adjusted HR: 3.00; 95% CI: 1.92 to 4.67; p < 0.001). The incidence rate of recurrent ventricular tachyarrhythmia in ASCD patients was 32.4 per 1,000 patient-years, and the composite of cardiac death and ventricular tachyarrhythmia was 44.9 per 1,000 patient-years. A total of 24 ASCD patients received implantable cardioverter-defibrillators (ICDs). There was a nonsignificant trend of a lower rate of cardiac death in patients with ICDs than those without ICDs (p = 0.15).
Conclusions:
The prognosis of patients with variant angina with ASCD was worse than other patients with variant angina. In addition, our findings supported ICDs in these high-risk patients as a secondary prevention because current multiple vasodilator therapy appeared to be less optimal.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Angina II: Classification
Coronary Artery Disease III: Clinical Manifestations
Angina III: Clinical Manifestations and Assessment
Introduction Cardiac Emergencies
Angina V: Nursing Management


